153 related articles for article (PubMed ID: 11131298)
1. Effect of Y-24180, a receptor antagonist to platelet-activating factor (PAF), on allergic cutaneous reactions in actively sensitized mice.
Yamaguchi S; Tomomatsu N; Komatsu H
Inflamm Res; 2000 Nov; 49(11):584-90. PubMed ID: 11131298
[TBL] [Abstract][Full Text] [Related]
2. Effect of Y-24180, an antagonist at platelet-activating factor (PAF) receptors, on IgE-mediated cutaneous reactions in mice.
Yamaguchi S; Tomomatsu N; Kagoshima M; Okumoto T; Komatsu H
Inflamm Res; 1998 Dec; 47(12):506-11. PubMed ID: 9892046
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of antiallergic drugs on IgE-mediated cutaneous reaction in passively sensitized mice.
Satoh T; Tahara E; Yamada T; Watanabe C; Itoh T; Terasawa K; Nagai H; Saiki I
Pharmacology; 2000 Feb; 60(2):97-104. PubMed ID: 10657759
[TBL] [Abstract][Full Text] [Related]
4. Suppressive effects of Y-24180, a receptor antagonist to platelet activating factor (PAF), on antigen-induced asthmatic responses in guinea pigs.
Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Matsuura M; Kawakami Y; Terasawa M
Inflamm Res; 1997 Apr; 46(4):147-53. PubMed ID: 9137994
[TBL] [Abstract][Full Text] [Related]
5. Effects of Y-24180, a receptor antagonist to platelet-activating factor, on allergic cutaneous eosinophilia in mice.
Yamaguchi S; Tomomatsu N; Kagoshima M; Okumoto T; Komatsu H
Life Sci; 1999; 64(11):PL139-44. PubMed ID: 10201647
[TBL] [Abstract][Full Text] [Related]
6. Suplatast tosilate inhibits eosinophil production and recruitment into the skin in murine contact sensitivity.
Satoh T; Sasaki G; Wu MH; Yokozeki H; Katayama I; Nishioka K
Clin Immunol; 2003 Sep; 108(3):257-62. PubMed ID: 14499249
[TBL] [Abstract][Full Text] [Related]
7. Suplatast tosilate inhibits goblet-cell metaplasia of airway epithelium in sensitized mice.
Shim JJ; Dabbagh K; Takeyama K; Burgel PR; Dao-Pick TP; Ueki IF; Nadel JA
J Allergy Clin Immunol; 2000 Apr; 105(4):739-45. PubMed ID: 10756224
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.
Asano K; Mizutani T; Shimane T; Hisano M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2000; 9(2):77-84. PubMed ID: 10958380
[TBL] [Abstract][Full Text] [Related]
9. Suplatast tosilate, a new type of antiallergic agent, prevents the expression of airway hyperresponsiveness in guinea pigs.
Taniguchi H; Togawa M; Ohwada K; Kiniwa M; Matsuura N; Nagai H; Koda A
Eur J Pharmacol; 1996 Dec; 318(2-3):447-54. PubMed ID: 9016937
[TBL] [Abstract][Full Text] [Related]
10. Effect of IPD-1151T (Suplatast Tosilate) on airway hyperresponsiveness in mice.
Konno S; Asano K; Gonokami Y; Kurokawa M; Kawazu K; Adachi M
Arerugi; 1995 May; 44(5):556-61. PubMed ID: 7619009
[TBL] [Abstract][Full Text] [Related]
11. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Kimata H
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
[TBL] [Abstract][Full Text] [Related]
12. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
Yoshihara S; Ono M; Yamada Y; Fukuda H; Abe T; Arisaka O
Pediatr Allergy Immunol; 2009 Aug; 20(5):486-92. PubMed ID: 19210644
[TBL] [Abstract][Full Text] [Related]
13. Suppressive effects of Y-24180, a long-acting antagonist for platelet-activating factor, on allergic pulmonary eosinophilia in mice.
Yamaguchi S; Kagoshima M; Kohge S; Terasawa M
Jpn J Pharmacol; 1997 Oct; 75(2):129-34. PubMed ID: 9414027
[TBL] [Abstract][Full Text] [Related]
14. [Effects of anti-PAF agents on nasal response after allergen challenge in guinea pigs].
Narita S; Asakura K; Shirasaki H; Kojima T; Saitoh H; Kataura A
Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1190-7. PubMed ID: 1357119
[TBL] [Abstract][Full Text] [Related]
15. Characterization of antihistamines using biphasic cutaneous reaction in BALB/c mice.
Inagaki N; Sakurai T; Abe T; Musoh K; Kawasaki H; Tsunematsu M; Nagai H
Life Sci; 1998; 63(11):PL 145-50. PubMed ID: 9747899
[TBL] [Abstract][Full Text] [Related]
16. An immunopharmacological study of the biphasic allergic skin reaction in mice.
Nagai H; Sakurai T; Inagaki N; Mori H
Biol Pharm Bull; 1995 Feb; 18(2):239-45. PubMed ID: 7742791
[TBL] [Abstract][Full Text] [Related]
17. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions.
Arias K; Baig M; Colangelo M; Chu D; Walker T; Goncharova S; Coyle A; Vadas P; Waserman S; Jordana M
J Allergy Clin Immunol; 2009 Aug; 124(2):307-14, 314.e1-2. PubMed ID: 19409603
[TBL] [Abstract][Full Text] [Related]
18. The roles of IL-4, IL-5 and mast cells in the accumulation of eosinophils during allergic cutaneous late phase reaction in mice.
Togawa M; Kiniwa M; Nagai H
Life Sci; 2001 Jun; 69(6):699-705. PubMed ID: 11476191
[TBL] [Abstract][Full Text] [Related]
19. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effect of suplatast tosilate on eosinophil migration].
Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
